167 related articles for article (PubMed ID: 8707353)
1. Interferon-gamma differentially regulates antigen-processing functions in distinct endocytic compartments of macrophages with constitutive expression of class II major histocompatibility complex molecules.
Hockett RD; Cook JR; Findlay K; Harding CV
Immunology; 1996 May; 88(1):68-75. PubMed ID: 8707353
[TBL] [Abstract][Full Text] [Related]
2. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
3. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.
Inaba K; Turley S; Iyoda T; Yamaide F; Shimoyama S; Reis e Sousa C; Germain RN; Mellman I; Steinman RM
J Exp Med; 2000 Mar; 191(6):927-36. PubMed ID: 10727455
[TBL] [Abstract][Full Text] [Related]
4. Distinct effects of recombinant cholera toxin B subunit and holotoxin on different stages of class II MHC antigen processing and presentation by macrophages.
Matousek MP; Nedrud JG; Harding CV
J Immunol; 1996 Jun; 156(11):4137-45. PubMed ID: 8666780
[TBL] [Abstract][Full Text] [Related]
5. Early endosomes and a late endocytic compartment generate different peptide-class II MHC complexes via distinct processing mechanisms.
Griffin JP; Chu R; Harding CV
J Immunol; 1997 Feb; 158(4):1523-32. PubMed ID: 9029086
[TBL] [Abstract][Full Text] [Related]
6. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells.
Harding CV; Geuze HJ
J Cell Biol; 1992 Nov; 119(3):531-42. PubMed ID: 1400590
[TBL] [Abstract][Full Text] [Related]
7. Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes.
Heise MT; Connick M; Virgin HW
J Exp Med; 1998 Apr; 187(7):1037-46. PubMed ID: 9529320
[TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 and IFN-gamma cross-regulate antigen presentation to CD4 T cells by macrophages.
Delvig AA; Lee JJ; Chrzanowska-Lightowlers ZM; Robinson JH
J Leukoc Biol; 2002 Jul; 72(1):163-6. PubMed ID: 12101276
[TBL] [Abstract][Full Text] [Related]
9. MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.
Leiter EH; Christianson GJ; Serreze DV; Ting AT; Worthen SM
J Exp Med; 1989 Oct; 170(4):1243-62. PubMed ID: 2507727
[TBL] [Abstract][Full Text] [Related]
10. Instability of expression of major histocompatibility antigens in fibroblasts expressing activated ras oncogene: constitutive and interferon-gamma induced class I and class II antigens in a series of clonal isolates of murine fibroblasts transformed by v-Ki-ras.
Morris AG; Ward GA; Bateman WJ
Br J Cancer; 1989 Aug; 60(2):211-5. PubMed ID: 2504267
[TBL] [Abstract][Full Text] [Related]
11. Leishmania donovani-infected macrophages: characterization of the parasitophorous vacuole and potential role of this organelle in antigen presentation.
Lang T; Hellio R; Kaye PM; Antoine JC
J Cell Sci; 1994 Aug; 107 ( Pt 8)():2137-50. PubMed ID: 7983173
[TBL] [Abstract][Full Text] [Related]
12. Endogenous and exogenous forms of the same antigen are processed from different pools to bind MHC class II molecules in endocytic compartments.
Bonifaz LC; Arzate S; Moreno J
Eur J Immunol; 1999 Jan; 29(1):119-31. PubMed ID: 9933093
[TBL] [Abstract][Full Text] [Related]
13. Intracellular organelles involved in antigen processing and the binding of peptides to class II MHC molecules.
Harding CV
Semin Immunol; 1995 Dec; 7(6):355-60. PubMed ID: 8775461
[TBL] [Abstract][Full Text] [Related]
14. Inhibition by chloroquine of the class II major histocompatibility complex-restricted presentation of endogenous antigens varies according to the cellular origin of the antigen-presenting cells, the nature of the T-cell epitope, and the responding T cell.
Lombard-Platlet S; Bertolino P; Deng H; Gerlier D; Rabourdin-Combe C
Immunology; 1993 Dec; 80(4):566-73. PubMed ID: 7508420
[TBL] [Abstract][Full Text] [Related]
15. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
16. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
[TBL] [Abstract][Full Text] [Related]
17. Selective immunosuppression by administration of major histocompatibility complex (MHC) class II-binding peptides. I. Evidence for in vivo MHC blockade preventing T cell activation.
Guéry JC; Sette A; Leighton J; Dragomir A; Adorini L
J Exp Med; 1992 May; 175(5):1345-52. PubMed ID: 1569402
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma mediates antigen trafficking to MHC class II-positive late endosomes of enterocytes.
Büning J; Schmitz M; Repenning B; Ludwig D; Schmidt MA; Strobel S; Zimmer KP
Eur J Immunol; 2005 Mar; 35(3):831-42. PubMed ID: 15688349
[TBL] [Abstract][Full Text] [Related]
19. Early endosomes are required for major histocompatiblity complex class II transport to peptide-loading compartments.
Brachet V; Péhau-Arnaudet G; Desaymard C; Raposo G; Amigorena S
Mol Biol Cell; 1999 Sep; 10(9):2891-904. PubMed ID: 10473634
[TBL] [Abstract][Full Text] [Related]
20. Survival of Salmonella enterica serovar Typhimurium within late endosomal-lysosomal compartments of B lymphocytes is associated with the inability to use the vacuolar alternative major histocompatibility complex class I antigen-processing pathway.
Rosales-Reyes R; Alpuche-Aranda C; Ramírez-Aguilar Mde L; Castro-Eguiluz AD; Ortiz-Navarrete V
Infect Immun; 2005 Jul; 73(7):3937-44. PubMed ID: 15972480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
